Answers are grounded in this paper and cite their sources.
The atypical follicular cell diagnosis in the new Bethesda System for Reporting Thyroid Cytopathology is a heterogeneous category without well‐defined cellular criteria and has the potential for overuse. Laboratories should monitor the use of this diagnosis.
No takes yet. Share an insight, caveat, or question.
Michael Henry (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: